Macroglobulinemia Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Clinical Trials

Study of Brexucabtagene Autoleucel in Adults With Rare B-cell Malignancies
Conditions:   Relapsed/Refractory Waldenstrom Macroglobulinemia;   Relapsed/Refractory Richter Transformation;   Relapsed/Refractory Burkitt Lymphoma;   Relapsed/Refractory Hairy Cell Leukemia Interventions:   Biological: Brexucabtagene Autoleucel;   Drug: Cyclophosphamide;   Drug: Fludarabine Sponsor:   Kite, A Gilead Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2022 Category: Research Source Type: clinical trials